NEW YORK (GenomeWeb) — Becton Dickinson will distribute AITbiotech's molecular assays in the Asia-Pacific region, the companies said late last week.

Under the agreement, Becton Dickinson Holdings, BD's Singapore-based subsidiary, will distribute AITbiotech's abTES BM qPCR assays optimized for use on the BD Max molecular testing system.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.